Teva Uk Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Teva Uk Limited

Patent Number:
Title:
Fluticasone Furoate In The Treatment Of Copd
Opposition Date:
Jun 6, 2024
Patent Number:
Title:
Methods For The Treatment Of Scleroderma
Opposition Date:
Feb 29, 2024
Patent Number:
Title:
Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same
Opposition Date:
Jul 13, 2021
Patent Number:
Title:
Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist
Applicant:
Opposition Date:
Sep 8, 2020
Patent Number:
Title:
Fluticasone Furoate In The Treatment Of Copd
Opposition Date:
Sep 8, 2020
Patent Number:
Title:
Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma
Opposition Date:
Mar 4, 2020
Patent Number:
Title:
Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol
Opposition Date:
Feb 21, 2020
Patent Number:
Title:
Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same
Opposition Date:
Jun 14, 2019
Patent Number:
Title:
Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation
Opposition Date:
Jun 5, 2019
Patent Number:
Title:
Dry Power Inhaler Devices And Dry Power Formulations For Enhancing Dosing Efficiency
Applicant:
Opposition Date:
Dec 21, 2018

Want to track Teva Uk Limited?

Feel free to send us a message here and we will get back to you